ISHARES ENERGY STORAGE& MATERIALS ETF IBAT 深 沪
已收盘 10-03 16:00:00 美东时间
29.37
+0.410
+1.42%
华盛通- 最 高29.41
- 今 开29.30
- 成交量 2013股
- 最 低 29.30
- 昨 收 28.96
- 总市值 822.36万
- 52周最高 29.95
- 市盈率 静 --
- 换手率 0.72%
- 52周最低 18.2314
- 委 比 22.58%
- 总股本 28.00万
- 历史最高 29.95
- 量 比 1.13
- 振 幅 0.38%
- 历史最低 18.2314
- 每 手 1
- 风险率 2.00%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多TABUK LAUNCHES VIBATIV® FDA-APPROVED ANTIBIOTIC WITH LIFE-SAVING POTENTIAL IN SAUDI ARABIA
Vibativ ® treats patients with pneumonia and serious skin infections NASHVILLE, Tenn. and RIYADH, Saudi Arabia, Sept. 29, 2025 /PRNewswire/ -- Specialty pharmaceutical companies Tabuk Pharm...
09-29 21:05
Demystifying Mirum Pharmaceuticals: Insights From 6 Analyst Reviews
Providing a diverse range of perspectives from bullish to bearish, 6 analysts h...
09-12 21:01
圣邦股份获得发明专利授权：“一种充电电流检测电路”
证券之星消息，根据天眼查APP数据显示圣邦股份（300661）新获得一项发明专利授权，专利名为“一种充电电流检测电路”，专利申请号为CN202011553779.1，授权日为2025年8月29日。
08-29 03:39
Deep Dive Into Mirum Pharmaceuticals Stock: Analyst Perspectives (6 Ratings)
In the last three months, 6 analysts have published ratings on Mirum Pharmaceut...
08-09 02:02
CUMBERLAND PHARMACEUTICALS RECEIVES VIZIENT CONTRACT FOR NEW VIBATIV® 4-VIAL STARTER PAK
Vizient serves more than 65% of the nation's acute care providers, including 97% of academic medical centers NASHVILLE, Tenn., Aug. 4, 2025 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (N...
08-04 21:05
葛兰素史克(GSK.US)口服靶向新药“利奈昔巴特片”在中国拟纳入优先审评
7月4日，中国国家药监局药品审评中心(CDE)官网公示，葛兰素史克(GSK.US)申报的利奈昔巴特片拟纳入优先审评。
07-04 10:44
International Battery Metals appoints Michael Rutledge as CFO
International Battery Metals (TSXV:IBAT:CA) announced on Monday the appointment of Michael Rutledge as chief financial officer (CFO) of the company. Prior to his appointment as CFO, Rutledge has serv...
06-03 04:55
GSK Announced Results From GLISTEN Phase 3 Trial Of Linerixibat In Adults With Cholestatic Pruritus And PBC, A Rare Autoimmune Liver Disease. The Full Data Were Presented In A Late-breaker Oral Presentation At The EASL Congress 2025
GLISTEN met the primary endpoint of change from baseline in monthly itch score and showed linerixibat (n=119) significantly improved itch versus placebo (n=119) over 24-weeks, as measured on a 0-10 numerical rating scale
05-08 18:23
International Battery Metals Ltd. Appoints Joseph A. Mills as CEO
International Battery Metals ( ($TSE:IBAT) ) has issued an announcement. Intern...
04-08 07:32
International Battery Metals appoints Michael Rutledge as interim CFO
International Battery Metals (TSXV:IBAT:CA) on Thursday said the board of directors has appointed Michael Rutledge as interim chief financial officer (CFO), effective immediately. Rutledge will assume...
03-07 02:35
